openPR Logo
Press release

In Depth Research on Global Insulin Patch Market Opportunity Analysis

10-04-2017 07:50 AM CET | Health & Medicine

Press release from: Kuick Resarch

In Depth Research on Global Insulin Patch Market Opportunity

" Global Insulin Patch Market Opportunity Analysis" Report Highlights:

* Introduction to Insulin Patch
* Mechanism Iontophoresis, Ultrasonic & Microneedle Insulin Patch
* Global Insulin Patch Market Analysis
* Global Insulin Patch Clinical Pipeline by Company, Indication & Phase
* Global Insulin Patch Clinical Pipeline: 9 Patches
* Highest Phase of Insulin Patch Development: Phase-II
* Insulin Patch Patent Analysis

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:https://www.kuickresearch.com/report-Global-Insulin-Patch-Market-Opportunity-Analysis.php

Table of Contents

1. Introduction to Insulin Patch

2. Comparison between Insulin Patches & Other Insulin Modalities

3. Mechanism of Insulin Patches
3.1 Iontophoresis Transdermal Insulin Delivery Patch
3.2 Ultrasonic Transdermal Insulin Delivery Patch
3.3 Microneedle Transdermal Insulin Delivery Patch

4. Emerging Trends in Insulin Delivery
4.1 Oral Insulin
4.2 Insulin Chewing Gum
4.3 Inhalable Insulin
4.4 Insulin Pumps and Patch Pump
4.5 Nanoparticle Insulin Delivery

5. Global Insulin Patch Market Analysis
5.1 Current Scenario
5.2 Insulin Patch Clinical Pipeline Overview

6. Global Insulin Patch Market Dynamics
6.1 Favorable Market Parameters
6.2 Commercialization Challenges

7. Future Prospects of Insulin Patch Market

8. Global Insulin Patch Clinical Pipeline by Company, Indication & Phase
8.1 Preclinical
8.2 Clinical
8.3 Phase-I
8.4 Phase-II
8.5 Phase-III
8.6 Preregistration

9. Discontinued Insulin Patch in Clinical Pipeline
9.1 Discontinued
9.2 No Development Reported

10. Competitive Landscape
10.1 Dermisonics
10.2 Encapsulation Systems
10.3 Encapsulife
10.4 Mesoblast
10.5 NeurogesX
10.6 NOLabs AB
10.7 Novo Nordisk
10.8 Phosphagenics
10.9 Relmada Therapeutics
10.10 Zosano Pharma

Figure 1-1: Benefits of Transdermal Insulin Patches
Figure 1-2: Improvement Required for Transdermal Insulin Patches
Figure 2-1: Necessity for Insulin Patches
Figure 2-2: Pharmacological Benefits of Insulin Patches
Figure 3-1: Types of Transdermal Patches
Figure 3-2: Requirements for Ideal Insulin Transdermal Patch
Figure 3-3: Benefits Observed During Clinical Trials
Figure 3-4: Benefits of Insulin Iontophoresis Patches
Figure 3-5: Consideration While Making Insulin Iontophoresis Patch
Figure 3-6: Mechanism of Iontophoresis Patches
Figure 3-7: Mechanism of Transdermal Ultrasonic Transfer
Figure 3-8: Benefits of Ultrasound Insulin Transfer
Figure 3-9: Mechanism of U-Strip
Figure 3-10: Benefits of Microneedles
Figure 3-11: Types of Microneedles
Figure 3-12: Mechanism of Microneedles
Figure 4-1: Different Modalities Insulin Transfer
Figure 5-1: Projected increase in diabetes cases
Figure 5-2: Insulin Patch Pipeline by Phase (%), 2015
Figure 5-3: Insulin Patch Pipeline by Phase (Number), 2015
Figure 5-4: Discontinued Insulin Patch Pipeline by Phase (%), 2015
Figure 5-5: Discontinued Insulin Patch Pipeline by Phase (Number), 2015
Figure 6-1: Global Insulin Patch Market Favorable Parameters
Figure 6-2: Global Insulin Patch Market Commercialization Challenges

Table 2-1: Comparison between Oral Insulin & Insulin Patch
Table 2-2: Comparison between Chewing Gum Insulin & Insulin Patch
Table 2-3:Comparison between Inhalable Insulin & Insulin Patch
Table 2-4: Comparison between Insulin Pump & Insulin Patches
Table 2-5: Comparison between Nanoparticle Insulin Products & Insulin Patches
Table 3-1: Comparative Analysis of Different Transdermal Insulin Patches
Table 4-1: Few Non-Conventional Insulin Products

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Depth Research on Global Insulin Patch Market Opportunity Analysis here

News-ID: 753643 • Views:

More Releases from Kuick Resarch

Lumakras Drug Clinical Insight and Sales Forecast 2026
Lumakras Drug Clinical Insight and Sales Forecast 2026
"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) * Pharmacokinetics of Lumakras (Sotorasib) * Dosage, Patent and Price Analysis * Lumakras Ongoing Clinical Trials * Global KRAS Protein Inhibitors Clinical Trials Download Report: https://www.kuickresearch.com/report-lumakras-sotorasib-sales-forecast-fda-approved-kras-inhibitor-clinical-trials-non-small-cell-lung-cancer-nslc-g12c-mutation-c30h30f2n6o3-ras-gtpase The rising burden of cancer and the increasing cancer mortality rates possesses an unmet need for the development of novel therapies in the management
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik (Tazemetostat) First Approved EZH2 Inhibitor Drug * Dosage, Price and Sales Analysis of Tazverik * Tazverik Sales Opportunity > US$ 900 Million by 2026 * Tazverik Sales Forecast 2021 Till 2026 * EZH2 Inhibitor Clinical Pipeline Overview By Company, Indication and Phase * EZH2 Inhibitor in Clinical Trials: 7 Drugs Download
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Tr …
"Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: * Global Bispecific Antibody Market Opportunity: > US$ 20 Billion * Global Bispecific Antibody Market Growth Rate: 100% CAGR (2016 -2021) * Approved Bispecific Antibodies In Market: 4 Antibodies * Detailed Market Sales and Trends Insight Till 2028 * Quarterly and Yearly Sales Insight Of Approved Antibodies Till Q1 2022 * Global and Regional Market Analysis * Approved Drug Sales
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and C …
"Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * Global FGFR Inhibitors Market Opportunity: > USD 4 Billion by 2026 * Role of FGFR Inhibitors in Cancer Therapy * Global FGFR Market Assessment (US$) by Region and Cancer Type Clinical and Sales Insight on Approved FGFR Inhibitors: 3 (Belvesra, Pemazyre and Truseltiq) * Dosage and Drug Price Insight on Approved FGFR Inhibitors * Comprehensive Clinical Trials Insight

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Bluetooth connected smart insulin pens represent the future of insulin delivery …
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development of ground-breaking products. Smart insulin pens are among such devices that have revolutionised the global market for diabetic injection pens. A recent study published by Future Market Insights projects that the global smart insulin pens market, which is currently valued at US$ 0.86 Mn, will expand vigorously at 17.9% CAGR through the
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin
Insulin Drug and Delivery Technologies Market Report 2018: Segmentation by Produ …
Global Insulin Drug and Delivery Technologies market research report provides company profile for Julphar, Ypsomed, Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
09-06-2017 | Health & Medicine
MRRSE
Smart Insulin Pens Market: Bluetooth Connected Smart Insulin Pens Allow Effectiv …
By connectivity, the Bluetooth connected smart insulin pen segment is expected to account for a value share of US$ 0.276 Mn in 2017. The segment is expected to reach a little more than US$ 2 Mn by 2027 end, registering the highest CAGR of 23.2% over the forecast period. Bluetooth connected smart insulin pens represent the future of insulin delivery devices. Such devices have an inbuilt Bluetooth connectivity feature allowing
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact